Today: September 3, 2015, 4:31 am
  

China osteoporosis drugs market: $1.6 billion industry in 2012

companiesandmarkets.com
companiesandmarkets.com
China Osteoporosis Market Outlook to 2017 - a new market research report on companiesandmarkets.com

 

PR-Inside.com: 2014-04-21 18:44:02
This report provides a comprehensive analysis of the various aspects such as market size, segmentation, trends and developments and future projections of the China Osteoporosis Market by number of diagnosed patients in the country, China Osteoporosis Drug Market with Teriparatide, Bisphosphonates, Traditional Chinese Medicine, Calcitonin, Strontium Ranelate and SERM as the key segments of the drug market.

The report also discusses in detail the osteoporotic diagnostic services and equipments in China with DXA and QUS being the broad categories. Finally the report also gives a brief snapshot of the Hong Kong and Taiwan Osteoporosis markets. A detailed explanation of the various macro and industry factors which are driving the growth of this market in China has also been provided.

Key Topics covered in the report:

- The market size of China Osteoporosis Market by number of osteoporosis patients diagnosed in the country.
- The market size of China Osteoporosis Drugs Market on the basis of revenue.
- The market segmentation of China Osteoporosis Drug Market by Teriparatide, Bisphosphonate, Traditional Chinese Medicine, Calcitonin, Strontium Ranelate and SERM.
- The market size and future outlook and projection for Teriparatide, Bisphosphonates, Traditional Chinese Medicine, Calcitonin, Strontium Ranelate and SERM on the basis of revenue.
- The future outlook and projections for China Osteoporosis Drug Market on the basis of revenue.
- Market share of major osteoporosis drug companies on the basis of revenue.
- The market size of China Fracture Surgery Market on the basis of revenue.
- The market segmentation China Fracture surgery market by vertebral fracture surgery and hip fracture surgery.
- The market size and future outlook and projections of vertebral fracture surgery market and hip fracture surgery market.
- The market size of China Osteoporosis Diagnostic services market.
- The market segmentation of China Osteoporosis Diagnostic services market by DXA scans and QUS scans.
- The market size and future outlook and projections for DXA scans and QUS scan market on the basis of revenue.
- The market size of China Diagnosis Equipment Market.
- The market segmentation of China Diagnosis Equipment Market by DXA machines and QUS machines
- The market size and future outlook and projections of DXA machines and QUS machines on the basis of revenue.
- Snapshots of Hong Kong and Taiwan Osteoporosis Market.

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Press Information


Published by
Mike King
London: +44 (0) 203 086 8600
e-mail
www.companiesandmarkets.com
Related Articles

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.